THE APPLICATION OF SULFASALAZIN AS AN INHIBITOR OF THE FORMATION OF END-GLYCATION PRODUCTS

摘要

The invention relates to medicine, namely to the treatment of socially significant diseases, such as complications of diabetes mellitus, atherosclerosis, rheumatoid arthritis, osteoarthritis, neurodegenerative diseases, including Alzheimer's and Parkinson's, cataracts, diseases associated with aging and others. The essence of the invention is the use for a new purpose as an inhibitor of the formation of end products of glycation of sulfasalazine (synonyms: salazosulfapyridine, Azopyrine, Asulfidine, Salazopyridin, Salazopyrin, Salazosulfapyridine, Salicylazosulfapyridin, Salisulf, Sulfasalazyn, Sulphasine formulas)